Research ArticleContinuing Education
SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer—Regulatory Process, Part II: The Role of the Institutional Review Board in Food and Drug Administration–Regulated Radiopharmaceutical Research
Charlotte D. Jeffers and John M. Hoffman
Journal of Nuclear Medicine Technology June 2022, 50 (2) 97-102; DOI: https://doi.org/10.2967/jnmt.122.264034
Charlotte D. Jeffers
1Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama;
John M. Hoffman
2Department of Radiology and Imaging Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah
In this issue
Journal of Nuclear Medicine Technology
Vol. 50, Issue 2
June 1, 2022
SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer—Regulatory Process, Part II: The Role of the Institutional Review Board in Food and Drug Administration–Regulated Radiopharmaceutical Research
Charlotte D. Jeffers, John M. Hoffman
Journal of Nuclear Medicine Technology Jun 2022, 50 (2) 97-102; DOI: 10.2967/jnmt.122.264034
SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer—Regulatory Process, Part II: The Role of the Institutional Review Board in Food and Drug Administration–Regulated Radiopharmaceutical Research
Charlotte D. Jeffers, John M. Hoffman
Journal of Nuclear Medicine Technology Jun 2022, 50 (2) 97-102; DOI: 10.2967/jnmt.122.264034
Jump to section
Related Articles
- No related articles found.